Genetic disease targeting creating antisense opportunity — antisense oligonucleotides (ASOs) — short synthetic DNA or RNA sequences designed to bind complementary mRNA sequences and modulate gene expression through RNase H-mediated degradation or steric blocking — enabling therapeutic targeting of previously undruggable genes and providing disease modification for genetic...